Clinical Trials Directory

Trials / Completed

CompletedNCT01593826

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.

Conditions

Interventions

TypeNameDescription
DRUGCharcoal and Budesonide/formoterol Easyhaler 320/9 microg2 inhalations as a single dose
DRUGCharcoal and Symbicort Turbuhaler2 inhalations as a single dose
DRUGBudesonide/formoterol Easyhaler 320/9 microg2 inhalations as a single dose
DRUGSymbicort Turbuhaler forte2 inhalations as a single dose

Timeline

Start date
2012-05-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2012-05-08
Last updated
2012-11-22

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01593826. Inclusion in this directory is not an endorsement.